NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Tuesday reported first-quarter profit of $341 million.
The New York-based company said it had profit of 56 cents per share. Earnings, adjusted for non-recurring costs, came to $1.60 per share.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.32 per share.
The company posted revenue of $684 million in the period. Its adjusted revenue was $1.13 billion, which also topped Street forecasts. Three analysts surveyed by Zacks expected $914.7 million.
Royalty Pharma expects full-year revenue in the range of $2.85 billion to $2.95 billion.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RPRX at https://www.zacks.com/ap/RPRX
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.